Suppr超能文献

头孢地嗪钠对小鼠的致畸学研究——器官发生期静脉给药

[Teratological study of cefodizime sodium in mice--intravenous administration during period of organogenesis].

作者信息

Kitatani T, Akaike M, Takayama K, Kobayashi T

机构信息

Pharma Research and Development Division, Hoechst Japan Limited, Saitama-ken.

出版信息

J Toxicol Sci. 1988 Jun;13 Suppl 1:191-214. doi: 10.2131/jts.13.supplementi_191.

Abstract

Cefodizime sodium (THR-221) was intravenously administered at dose levels of 300, 1000 and 3000 mg/kg/day to pregnant mice on days 6-15 of gestation covering the period of organogenesis, and its effects on the dams (F0) and the fetal and postnatal development and fertility of their offspring (F1) were examined. In each group including a control group, 21-24 of the 33-38 F0 dams were submitted to cesarean section on day 18 of gestation, and the remaining 12-14 animals were allowed to litter normally and nurse their offspring until day 21 of lactation. In the F0 dams, no compound effects were seen in general conditions, body weight, food consumption, numbers of corpora lutea and implantations or duration of gestation. The thymus weights of the cesarean sectioned dams at 1000 and 3000 mg/kg/day were less than the control values, but no difference appeared in weights of the other main organs between any treatment group and the control group. No gross visceral abnormalities were noted at any dose. In F1 near-term fetuses, the compound administration exerted no effects on their development at any dose, except the decreased body weight and crown-rump length noted at 3000 mg/kg/day. No difference occurred in incidence of fetuses with external, visceral or skeletal anomalies between any treatment group and the control group. Normally delivered F1 offspring in the treatment groups exhibited no changes from the controls in postnatal development, reflexes, 21-day survival index or behavioral test performance. Skeletal examination on F1 offspring which died during lactation and autopsies on the other animals at the end of study revealed no compound-related abnormalities. The fertility of the F1 mice was normal at all doses, and there were no compound effects on the F1 dams or their near-term fetuses or newborn pups. From the present results, it is considered that the no-effect doses of THR-221 for the maternal mice and their offspring are 300 and 1000 mg/kg/day, respectively.

摘要

在妊娠第6至15天(涵盖器官发生期),以300、1000和3000毫克/千克/天的剂量水平对怀孕小鼠静脉注射头孢地嗪钠(THR - 221),并研究其对母鼠(F0)及其后代(F1)的胎儿、产后发育和生育能力的影响。在包括对照组在内的每组中,33 - 38只F0母鼠中有21 - 24只在妊娠第18天接受剖腹产,其余12 - 14只动物正常产仔并哺育后代至哺乳期第21天。在F0母鼠中,一般状况、体重、食物摄入量、黄体数、着床数或妊娠期均未观察到化合物相关影响。1000和3000毫克/千克/天剂量下剖腹产母鼠的胸腺重量低于对照值,但任何治疗组与对照组之间其他主要器官的重量均无差异。任何剂量下均未观察到明显的内脏异常。在F1近足月胎儿中,化合物给药在任何剂量下对其发育均无影响,但在3000毫克/千克/天剂量下观察到体重和顶臀长度下降。任何治疗组与对照组之间,有外部、内脏或骨骼异常的胎儿发生率无差异。治疗组中正常分娩的F1后代在产后发育、反射、21天存活指数或行为测试表现方面与对照组相比无变化。对哺乳期死亡的F1后代进行骨骼检查以及在研究结束时对其他动物进行尸检,均未发现与化合物相关的异常。F1小鼠在所有剂量下生育能力均正常,且对F1母鼠及其近足月胎儿或新生幼崽均无化合物相关影响。根据目前的结果,认为THR - 221对母鼠及其后代的无效应剂量分别为300和1000毫克/千克/天。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验